CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2022; 12(03): 267-273
DOI: 10.1055/s-0041-1740025
Original Article

Knowledge of Polycystic Ovarian Syndrome, Its Complications, and Management among Lebanese Women: A Cross-Sectional Survey

Farah Al Souheil
1   Biomedical Sciences Department, School of Pharmacy, Lebanese International University, Beirut, Lebanon
,
Bahia Chahine
1   Biomedical Sciences Department, School of Pharmacy, Lebanese International University, Beirut, Lebanon
› Author Affiliations

Abstract

Introduction Polycystic ovarian syndrome (PCOS) is a multi-spectrum disease where a failure to address it correctly can result in various clinical complications. This study aimed to assess the Lebanese women's knowledge and perceptions of PCOS and its management.

Materials and Methods This cross-sectional study included women whose ages ranged between 18 and 45 years. Women's demographic characteristics, reproductive health, knowledge, and perception of PCOS were analyzed through an online validated questionnaire.

Results Among the 450 included women, 196 (43.6%) had good knowledge about PCOS. The majority of participants were aware that menstrual irregularity is a symptom of PCOS, 327 (72.7%), while only 231 (51.3%) women knew that PCOS may lead to infertility. Almost two-thirds of women were aware of the contribution of metformin, diet, and exercise in refining the progress of the disease. More than 60% of participants believed that PCOS patients need social support and have a low body image. Married women (p < 0.001) and those with undergraduate/ postgraduate degrees (p < 0.001) had better PCOS knowledge.

Conclusion A significant percentage of Lebanese women have inadequate knowledge of PCOS and its complications.

Authors' Contributions

F.A. collected the data. F.A. and B.C. analyzed the data and were involved in writing and reviewing the final version of the manuscript.


Ethics Approval

Ethical approval was obtained for the study.


Availability of Data and Material

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.




Publication History

Article published online:
01 December 2021

© 2021. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016; 31 (12) 2841-2855
  • 2 Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online 2004; 8 (06) 644-648
  • 3 Strowitzki T, Capp E, von Eye Corleta H. The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients. Eur J Obstet Gynecol Reprod Biol 2010; 149 (02) 178-181
  • 4 Orio F, Palomba S. Reproductive endocrinology: new guidelines for the diagnosis and treatment of PCOS. Nat Rev Endocrinol 2014; 10 (03) 130-132
  • 5 Das M, Djahanbakhch O, Hacihanefioglu B. et al. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93 (03) 881-887
  • 6 Nelson VL, Legro RS, Strauss III JF, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 1999; 13 (06) 946-957
  • 7 Chen ZJ, Zhao H, He L. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011; 43 (01) 55-59
  • 8 Dallel M, Douma Z, Finan RR. et al. Contrasting association of Leptin receptor polymorphisms and haplotypes with polycystic ovary syndrome in Bahraini and Tunisian women: a case-control study. Biosci Rep 2021; 41 (01) BSR20202726
  • 9 Pitchai P, Sreeraj SR, Anil PR. Awareness of lifestyle modification in females diagnosed with polycystic ovarian syndrome in India: explorative study. Int J Reprod Contracept Obstet Gynecol 2016; 5 (02) 470-476
  • 10 Ding T, Hardiman PJ, Petersen I, Baio G. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study. Hum Reprod 2018; 33 (07) 1299-1306
  • 11 Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005; 90 (08) 4650-4658
  • 12 Hart R, Doherty DA, Mori T. et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril 2011; 95 (07) 2347-2353 , 2353.e1
  • 13 Månsson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landén M. Women with polycystic ovary syndrome are often depressed or anxious–a case control study. Psychoneuroendocrinology 2008; 33 (08) 1132-1138
  • 14 Patel J, Rai S. Polycystic ovarian syndrome (PCOS) awareness among young women of central India. Int J Reprod Contracept Obstet Gynecol 2018; 7 (10) 3960-3964
  • 15 Haq N, Khan Z, Riaz S, Nasim A, Shahwani R, Tahir M. Prevalence and knowledge of polycystic ovary syndrome (PCOS) among female science students of different public universities of Quetta, Pakistan. Imperial J Interdisciplin Res 2017; 3 (06) 385-392
  • 16 AlSinan A, Shaman AA. A study to measure the health awareness of polycystic ovarian syndrome in Saudi Arabia. GJHS 2017; 9 (08) 130-138
  • 17 Abu-Taha M, Daghash A, Daghash R, Abu Farha R. Evaluation of women knowledge and perception about polycystic ovary syndrome and its management in Jordan: a survey-based study. Int J Clin Pract 2020; 74 (10) e13552
  • 18 Avery JC, Braunack-Mayer AJ. The information needs of women diagnosed with Polycystic Ovarian Syndrome–implications for treatment and health outcomes. BMC Womens Health 2007; 7: 9
  • 19 Colwell K, Lujan ME, Lawson KL, Pierson RA, Chizen DR. Women's perceptions of polycystic ovary syndrome following participation in a clinical research study: implications for knowledge, feelings, and daily health practices. J Obstet Gynaecol Can 2010; 32 (05) 453-459
  • 20 Ryan H, Trosclair A, Gfroerer J. Adult current smoking: differences in definitions and prevalence estimates–NHIS and NSDUH, 2008. J Environ Public Health 2012; 2012: 918368
  • 21 Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget 2017; 8 (56) 96351-96358
  • 22 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
  • 23 Ekbäck MP, Lindberg M, Benzein E, Årestedt K. Social support: an important factor for quality of life in women with hirsutism. Health Qual Life Outcomes 2014; 12: 183
  • 24 Hamdanieh M, Ftouni L, Al Jardali B. et al. Assessment of sexual and reproductive health knowledge and awareness among single unmarried women living in Lebanon: a cross-sectional study. Reprod Health 2021; 18 (01) 24 DOI: 10.1186/s12978-021-01079-x.
  • 25 Alessa A, Aleid D, Almutairi S. et al. Awareness of polycystic ovarian syndrome among Saudi females. Int J Med Sci Public Health 2017; 6 (06) 1013-1019